Duration of Long Acting Muscarinic Antagonist (LAMA) Bronchoprotection Against Methacholine Challenge
Condition(s):AsthmaLast Updated:April 20, 2016Completed
Hide Studies Not Open or Pending
Condition(s):AsthmaLast Updated:April 20, 2016Completed
Condition(s):COPDLast Updated:January 19, 2021Completed
Condition(s):Anesthesia, GeneralLast Updated:March 19, 2019Completed
Condition(s):Reversal of Neuromuscular BlockadeLast Updated:October 8, 2020Completed
Condition(s):Headache; Tumor; Seizure Disorder; Neurofibromatoses; Hydrocephalus; Abdominal Neoplasm; Spine DeformityLast Updated:February 21, 2020Completed
Condition(s):Postoperative Urinary RetentionLast Updated:July 25, 2023Recruiting
Condition(s):Neuromuscular Blockade; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Blood Coagulation; Antithrombotic AgentsLast Updated:February 12, 2021Completed
Condition(s):Airway Reflexes, Protective; Recovery After Neuromuscular Block; Anesthetic RecoveryLast Updated:May 16, 2014Completed
Condition(s):Neuromuscular BlockadeLast Updated:January 28, 2021Completed
Condition(s):RhytidoplastyLast Updated:April 7, 2015Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.